a b c d e f g h i j k l m n o p q r s t u v w x y z #

Items starting with I Files

I.V.-Globulin SN Inj. (50 mg/mL) 352C17011

  • Date of Issuance: 16-Jan-18

Imojev 08A1401EB

  • Date of Issuance: 1-Jun-16

Imojev 08A1401EB

  • Date of Issuance: 5-May-16

Imojev 08A1404EB

  • Date of Issuance: 30-Sep-15

Imojev 08A1404EB (2)

  • Date of Issuance: 4-Jun-15

Imojev 08A1404EB (3)

  • Date of Issuance: 30-Sep-15

Imojev 08A1406EA

  • Date of Issuance: 30-Sep-15

Imojev 08A1406EA

  • Date of Issuance: 29-Oct-15

Imojev 08A1406EB

  • Date of Issuance: 24-Feb-16

Imojev 08A1502BB

  • Date of Issuance: 1-Jun-16

Imojev 08A1505EA

  • Date of Issuance: 17-Jun-16

Imojev 08A1505EA

  • Date of Issuance: 24-Feb-16

Imojev 08A1505EB (2)

  • Date of Issuance: 17-Jun-16

Imojev 08A1506EA

  • Date of Issuance: 17-Aug-16

Imojev 08A1506EA

  • Date of Issuance: 25-Jul-16

Imojev 08A1506EB

  • Date of Issuance: 17-Aug-16

Imojev 08A1509EA

  • Date of Issuance: 16-Dec-16

Imojev 08A1509EA

  • Date of Issuance: 4-Oct-16

Imojev 08A1509EA

  • Date of Issuance: 17-Aug-16

Imojev 08A1509EB

  • Date of Issuance: 4-Oct-16

Imojev 08A1512EA

  • Date of Issuance: 16-Dec-16
[12 3 4  >>  

National Pharmaceutical Regulatory Agency (NPRA)
Lot 36, Jalan Universiti, 46200 Petaling Jaya, Selangor, Malaysia.
  • Email: npra@npra.gov.my
  • Phone: +603-7883 5400
  • Fax: +603-7956 2924, +603-7956 7075

DISCLAIMER

The Government of Malaysia and the National Pharmaceutical Regulatory Agency are not responsible for any loss or damage caused by the usage of any information obtained from this website.

Mobile Web :

Newsletter Subsription

Site Last Modified

  • Last Modified: Monday 10 December 2018, 14:32:16.
© Copyright 2018 . All Rights Reserved National Pharmaceutical Regulatory Agency NPRA